2021年7月9日 星期五

The Daily: What Is Critical Race Theory?

And how to learn more about the issue dividing school districts across the country.
Protesting against the teaching of critical race theory, at the Loudoun County Government Center in Leesburg, Va., in June.Andrew Caballero-Reynolds/Agence France-Presse — Getty Images

We had a shorter holiday week on The Daily, but we covered a lot of ground, traveling from Afghanistan to Haiti. Along the way, many of you wrote in to share your thoughts and feelings about our episode on critical race theory.

It's a complicated subject with a lot of history and nuance to unpack, and some of you were interested in learning more. So we reached out to Trip Gabriel, a national correspondent and our guest, to answer some of your questions.

What is critical race theory (C.R.T.)?

Critical race theory is a concept, once the domain of graduate schools, that some observers say is now influencing American K-12 curriculums. The theory argues that historical patterns of racism are ingrained in law and other modern institutions, and that the legacies of slavery, segregation and Jim Crow still create an uneven playing field for Black people and other people of color. The idea is that racism is not a matter of individual bigotry but is systemic in America. Recently critics have made C.R.T. a catchall target for opposition to equity efforts, affirmative action and "wokeness" in general.

Conservatives object that critical race theory is a gauntlet thrown down to accuse all white Americans of being racist, of dividing people by race into oppressors and oppressed. Democrats are conflicted. Some worry that arguing that America is racist to the root — a view that is conventional wisdom among elements of the party's progressive wing — contradicts the opinion of most Americans and is handing Republicans a political cudgel for the 2022 midterm elections.

Do you have any examples of how C.R.T. is being taught in schools?

You'd have to look long and hard to find any K-12 classroom where the term "critical race theory" comes up. Instead, what critics tend to target is the influence of concepts derived from C.R.T. that infuse the equity training field (some examples include acknowledging and subverting white privilege, or labeling people as oppressors or oppressed based on identity). This kind of training has been offered by various school districts to teachers in the name of combating implicit bias.

ADVERTISEMENT

While the anti-C.R.T. activist Christoper F. Rufo lists 11 examples of "critical race theory in education," most are examples of schools offering teachers diversity training. He also cites a lesson planned for third graders in Cupertino, Calif., in which students were asked to draw an "identity map" listing their race, class and gender, and the teacher was asked to identify some characteristics as part of the "dominant culture." But according to The Washington Post, the lesson was canceled after one use when parents complained.

Meanwhile, some schools have recommended to young readers the book "Not My Idea: A Book About Whiteness,'' which, in discussing the police shooting of a person of color, makes the point that white supremacy is embedded in American society.

The show covered criticisms of C.R.T. from the right. Is there criticism of the theory from the left?

Some classical liberals have argued that critical race theory rejects concepts like meritocracy, individualism and unbridled free speech, which it deems products of a white dominant culture. Taking a different angle, John McWhorter, an author who teaches at Columbia University, argues that C.R.T. as interpreted by the anti-racism training field "diminishes Black people in the name of dignifying us."

What should listeners read if they want to learn more about C.R.T.?

A seminal book by some of the founding scholars of the academic movement is "Words That Wound'' (1993). The introductory chapters of "Critical Race Theory: An Introduction" (2001) lay out the movement's genesis and principal views.

ADVERTISEMENT

In recent months, there have been good explainers in the press about how America's reckoning over systemic racism in policing brought new prominence to critical race theory — and provoked a backlash. I found this piece by Fabiola Cineas in Vox helpful, along with this column by Michelle Goldberg of The Times. A deep dive into the related topic of anti-bias training — inspired partly by C.R.T. — can be found in a Times Magazine profile of Robin DiAngelo, author of "White Fragility," by Daniel Bergner. Adam Harris in The Atlantic took a look at bills in state legislatures seeking to ban "divisive concepts" in education and elsewhere. And Wikipedia (insert usual caveats) has a quite comprehensive look.

Talk to Trip on Twitter: @tripgabriel.

Holding Onto Hope

Debby Rosenkrantz, a trial participant for an experimental Alzheimer's drug, spoke with The Daily on Wednesday's episode.Kayana Szymczak for The New York Times

Pam Belluck, a health and science writer, reflects on her recent reporting on Aduhelm, a controversial new Alzheimer's drug, through one family's experience with it:

ADVERTISEMENT

By the time I had interviewed Debby Rosenkrantz and Susan Woskie for The Daily, I had been covering Alzheimer's and dementia for more than a decade.

I've traveled to Colombia to report about the world's largest family with genetic early-onset Alzheimer's; went to South Korea to write about children being trained to assist people with dementia; and spent time in a California men's prison to observe how convicted murderers were helping fellow prisoners with dementia with activities like showering, shaving and eating. I've written about how dementia might affect the ability to give sexual consent. And this past year I've written about Covid and dementia.

I've become well aware of the complexities and cruelties of this condition, and I've followed the roller-coaster ride of the search for answers — from discoveries of a gene mutation that might protect against Alzheimer's to out-of-the-box therapeutic approaches like using flickering light and sound.

As I've been talking with patients and family members for my recent reporting on the new drug, Aduhelm, what has struck me most is how thoughtful and insightful they've been about the difficult situation they find themselves in. Several people I've interviewed are clear-eyed and candid about their poignant reality, including Debby and her wife, Susan.

The couple knows that so far Debby, who participated in the clinical trial of Aduhelm and began receiving monthly infusions of it again about 10 months ago, has experienced no discernible benefit from the drug. "It just feels like there's a blank in places where there shouldn't be a blank in my brain," Debby told me.

They understand the drug can cause brain swelling or brain bleeding, and Debby undergoes regular brain scans to check for such effects. And Susan, a retired professor of public health, told me before the F.D.A. decision that the data about the drug was "squishy stuff" and that if the F.D.A. decided not to approve it, "that wouldn't surprise me, and it might make sense."

And yet they have decided to continue giving the drug a try. They are doing so because they realize there is nothing else out there for them yet. Maybe doing something, whether it's taking an unproven drug or exercising or changing one's diet, can give some people a sense of hope that might be therapeutic in itself. In a devastating, unpredictable disease that little by little steals away part of one's mind, hope may actually be the best medicine available right now.

Talk to Pam on Twitter: @PamBelluck.

On The Daily this week

Tuesday: What we know about the Delta variant.

Wednesday: Inside the lived reality of a contentious Alzheimer's treatment.

Thursday: The American withdrawal from Afghanistan.

Friday: A presidential assassination in Haiti.

That's it for The Daily newsletter. See you next week.

Have thoughts about the show? Tell us what you think at thedaily@nytimes.com.

Were you forwarded this newsletter? Subscribe here to get it delivered to your inbox.

Love podcasts? Join The New York Times Podcast Club on Facebook.

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for The Daily from The New York Times.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

LiveIntent LogoAdChoices Logo

The New York Times Company. 620 Eighth Avenue New York, NY 10018

Wonking out: mRNA and the meaning of life

Americans are suddenly feeling good. Why?
Emile Ducke for The New York Times
Author Headshot

By Paul Krugman

Opinion Columnist

Alert! Wonk warning! This is an additional email that goes deeper than usual into the economics and some technical stuff.

Happy days are here again. No, really. Gallup has been asking Americans since the beginning of 2008 whether they are "thriving." The percentage answering yes hit a low point in the depths of the 2008 financial crisis and again during the worst of the Covid-19 pandemic. But it has soared in recent months, to 59.2 percent, its highest level ever:

Striving to thrive.Gallup

For what it's worth, Gallup's number deserves to be taken seriously. The question "Are you thriving?" is pretty close to the question "Overall, how satisfied are you with your life?," which is widely used by eminent scholars like Angus Deaton and reported on a regular basis by international agencies. So the surging number of Americans who say that they're thriving is meaningful, and it's worth asking for an explanation.

What do we know about life satisfaction? At an individual level, it's overwhelmingly about relationships and health (especially mental health). Income is a factor but a relatively minor one. Americans differ vastly from one another in how happy they are with their lives, but most of that variation reflects personal factors rather than money: There are miserable billionaires and cheerful families barely scraping by.

ADVERTISEMENT

When we're looking at either changes in national life satisfaction or differences among countries, however, the social aspects of happiness tend to average out, so income stands out more clearly. There is a strong correlation across countries between per capita income and life satisfaction, although with some interesting deviations:

Rich is better.Our World in Data

Notably, citizens of Nordic nations like Denmark seem more satisfied with their lives than you might expect given their incomes. The security of a strong social safety net may have a lot to do with this success story. They may also do better than we do at work-life balance:

ADVERTISEMENT

All work and no play takes a toll.OECD

OK, I can't resist mentioning a report on the evils of socialism from Donald Trump's economic advisers, who insisted that life must be bad in the Nordics because it's hard for workers to afford pickup trucks:

The pickup theory of value.Council of Economic Advisers

You might ask why Costa Rica appears to be so happy and Japan less happy than Mexico. The answer is that I don't know enough to weigh in on those questions.

ADVERTISEMENT

Anyway, the economy matters. But it's probably not the main reason for surging life satisfaction in America right now. Why? Because we did an impressively good job — not perfect, by any means, but impressive all the same — of supporting families through the hardships of the pandemic slump. Government aid was, in fact, so generous that personal incomes on average actually rose in the pandemic:

We got by with a little help from our ... government.FRED

So what does account for the happiness boom? My best guess is that over the course of the pandemic the social factors that hugely affect personal life satisfaction, but on average usually don't change much over time, went through huge swings. For many months Americans were cooped up in their homes, unable to hang out with friends, in some cases unable to visit even close family. Then came the vaccines, and for many of us, life took a big step back toward normal.

People being what they are, the joy of normality will probably fade over time as we get reaccustomed to our old routines. And there will surely be a huge plunge in happiness if the refusal of many Americans to get vaccinated leads to a Covid resurgence.

But for now, we're feeling pretty good.

Subscribe Today

New York Times Opinion curates a wide range of views, inviting rich discussion and debate that helps readers analyze the world. This work is made possible with the support of subscribers. Please consider subscribing to The Times with this special offer.

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for Paul Krugman from The New York Times.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

LiveIntent LogoAdChoices Logo

The New York Times Company. 620 Eighth Avenue New York, NY 10018